Want to track RNAC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cartesian Therapeutics Inc. (RNAC) Statistics
Valuation metrics
Market Cap 242.69M
Enterprise value 135.91M
Trailing P/E (ttm) -1.43
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 136.73
Price/Book (mrq) -1.5
Enterprise Value/Revenue 76.57
Enterprise Value/EBITDA -0.86
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 145.16K
Average volume (90 days) 215.54K
Price summary
52-Week low 5.6
52-Week high 14.56
Beta -
50-Day moving average 8.89
200-Day moving average 7.21
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 5 Apr 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -85.51%
Operating margin -51.45%
Operational effectiveness
Return on assets -0.53%
Return on equity 1.94%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.07
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -5.65
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.42
Total debt (mrq) -
Total Debt/Equity (mrq) -0.08
Current ratio (mrq) 7.65%
Book value per share (mrq) -5.52
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
